Talk
Approved and abandoned: why 90% of devices die without lifecycle strategy
Tue, Jun 3, 2025 · 4:15–4:45 PM CDT Minneapolis Marriott West
About this session
Regulatory approval is no longer the finish line—it’s just the starting point. In today’s MedTech landscape, clinical success alone doesn’t guarantee market survival. This session offers a lifecycle-driven blueprint that integrates clinical, regulatory, reimbursement, and market strategy from the start. Through real-world cases and usable frameworks, you’ll learn how to build devices that get adopted, paid for, and scaled. In this session we will explore:
- How clinical trial design can sabotage reimbursement success and how to fix it
- A blueprint for integrating clinical, regulatory, and market access planning
- Real-world examples where lifecycle thinking saved or doomed devices
- A checklist for building lifecycle-centric strategies from day one
- A high value bonus handoutwill be provided to those who attend the talk
